Aprepitant Teva 125 mg + 80 mg tvrde kapsule
Name | Aprepitant Teva 125 mg + 80 mg tvrde kapsule |
---|---|
Marketing Authorisation Number | HR-H-083770930 |
Active Substance | aprepitant |
Composition | jedna kapsula od 125 mg sadrži 125 mg aprepitanta jedna kapsula od 80 mg sadrži 80 mg aprepitanta |
Pharmaceutical Form | kapsula, tvrda |
Manufacturer | Teva Operations Poland Sp. z o.o., Krakow, Poljska Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka Rontis Hellas Medical and Pharmaceutical Products S.A., Atena, Maroussi, Grčka |
Marketing Authorisation Holder | Teva B.V., Swensweg 5, Haarlem, Nizozemska |
Marketing Authorisation Date | 31.03.2023 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/22-02/133 |
Registration Number | 381-12-01/70-23-04 |
Prescription | na recept |
Type of prescription | neponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | A04AD12 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |